Monometacrine
 | |
| Clinical data | |
|---|---|
| Other names | Desmethyldimetacrine; Nordimetacrine; N-Desmethyldimetacrine; SD-735; NSC-100296 |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C19H24N2 |
| Molar mass | 280.415 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Monometacrine (INN; developmental code name SD-735), also known as desmethyldimetacrine, is a drug of the tricyclic family described as an antidepressant which was never marketed.[1][2][3] It was first described in the literature by 1966.[1] The drug is the N-desmethyl analogue of dimetacrine and is a metabolite of dimetacrine.[1][3]
References
[edit]- ^ a b c Elks J (2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. p. 835. ISBN 978-1-4757-2085-3. Retrieved 20 October 2024.
- ^ Negwer M, Scharnow HG (2001). Organic-chemical Drugs and Their Synonyms: An International Survey. Wiley-VCH. p. 1788. ISBN 978-3-527-30247-5. Retrieved 20 October 2024.
- ^ a b "Monometacrine". Inxight Drugs. National Center for Advancing Translational Sciences (NCATS). Retrieved 20 October 2024.
 | This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it. |